LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Product Launch Cytokinetics has launched 'HCM Beyond the Heart,' raising awareness about hypertrophic cardiomyopathy (HCM) among healthcare professionals, presenting an opportunity for sales teams to engage cardiologists and HCPs with potential muscle activator treatments.

Investment Interest Recent investments from Armistice Capital and Bridger Capital LLC indicate growing investor confidence in Cytokinetics, signaling potential business development opportunities for collaboration or partnerships.

Successful IPO Following its successful IPO, Cytokinetics received substantial upfront capital and equity investments, showcasing financial stability and potential expansion plans that could lead to sales growth opportunities for service providers or suppliers.

Innovative Drug Development With ongoing development of drug candidates like CK-586 and CK-136 for heart failure treatment, Cytokinetics presents a target market for pharmaceutical companies looking to collaborate or license innovative therapies.

Market Expansion Potential Cytokinetics' focus on muscle biology research and commercializing muscle activators opens avenues for sales teams targeting healthcare providers and patients, offering solutions for muscle-related illnesses and presenting sales growth opportunities in the healthcare sector.

Similar companies to Cytokinetics

Cytokinetics Tech Stack

Cytokinetics uses 8 technology products and services including SAS, Docebo, Oracle, and more. Explore Cytokinetics's tech stack below.

  • SAS
    Business Intelligence
  • Docebo
    Corporate Learning Management Systems
  • Oracle
    Enterprise
  • Greenhouse
    Recruitment Marketing
  • Cloudflare Bot Management
    Security
  • X-XSS-Protection
    Security
  • Concur
    Travel And Expense Management
  • ShareThis
    Widgets

Media & News

Cytokinetics's Email Address Formats

Cytokinetics uses at least 1 format(s):
Cytokinetics Email FormatsExamplePercentage
FLast@cytokinetics.comJDoe@cytokinetics.com
91%
FiLast@cytokinetics.comJoDoe@cytokinetics.com
4%
FirLast@cytokinetics.comJohDoe@cytokinetics.com
3%
FirstLas@cytokinetics.comJohnDoe@cytokinetics.com
2%

Frequently Asked Questions

Where is Cytokinetics's headquarters located?

Minus sign iconPlus sign icon
Cytokinetics's main headquarters is located at 350 Oyster Point Blvd South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Cytokinetics's phone number?

Minus sign iconPlus sign icon
You can contact Cytokinetics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cytokinetics's stock symbol?

Minus sign iconPlus sign icon
Cytokinetics is a publicly traded company; the company's stock symbol is CYTK.

What is Cytokinetics's official website and social media links?

Minus sign iconPlus sign icon
Cytokinetics's official website is cytokinetics.com and has social profiles on LinkedIn.

How much revenue does Cytokinetics generate?

Minus sign iconPlus sign icon
As of September 2024, Cytokinetics's annual revenue reached $75M.

What is Cytokinetics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cytokinetics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cytokinetics have currently?

Minus sign iconPlus sign icon
As of September 2024, Cytokinetics has approximately 514 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Compliance Officer And Legal Counsel: E. A.Chief Medical Officer: S. K.Chief Commercial Officer: T. P.. Explore Cytokinetics's employee directory with LeadIQ.

What industry does Cytokinetics belong to?

Minus sign iconPlus sign icon
Cytokinetics operates in the Biotechnology Research industry.

What technology does Cytokinetics use?

Minus sign iconPlus sign icon
Cytokinetics's tech stack includes SASDoceboOracleGreenhouseCloudflare Bot ManagementX-XSS-ProtectionConcurShareThis.

What is Cytokinetics's email format?

Minus sign iconPlus sign icon
Cytokinetics's email format typically follows the pattern of . Find more Cytokinetics email formats with LeadIQ.

How much funding has Cytokinetics raised to date?

Minus sign iconPlus sign icon
As of September 2024, Cytokinetics has raised $550M in funding. The last funding round occurred on May 22, 2024 for $550M.

When was Cytokinetics founded?

Minus sign iconPlus sign icon
Cytokinetics was founded in 1998.
Cytokinetics

Cytokinetics

Biotechnology ResearchCalifornia, United States501-1000 Employees

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. 

Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.

Section iconCompany Overview

Headquarters
350 Oyster Point Blvd South San Francisco, California 94080 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CYTK
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
501-1000

Section iconFunding & Financials

  • $550M

    Cytokinetics has raised a total of $550M of funding over 11 rounds. Their latest funding round was raised on May 22, 2024 in the amount of $550M.

  • $50M$100M

    Cytokinetics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $550M

    Cytokinetics has raised a total of $550M of funding over 11 rounds. Their latest funding round was raised on May 22, 2024 in the amount of $550M.

  • $50M$100M

    Cytokinetics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.